NCT00001430View on ClinicalTrials.gov

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 1995

Study Completion Date

January 31, 2002

Conditions
Hodgkin's DiseaseNon Hodgkin's Lymphoma
Interventions
PROCEDURE

PBSC

DRUG

IL-2

DRUG

EPOCH II

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001430 - A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas | Biotech Hunter | Biotech Hunter